Malta vs Syria: Access to anti-retroviral drugs, female (%)
Malta
47.0%
in 2024
Syria
41.0%
in 2024
Malta rank
124th
Syria rank
127th
Access to anti-retroviral drugs, female (%) over time
- Malta
- Syria
How they compare
Malta currently reports 47.0% against 41.0% in Syria, a difference of 6.0%.
That makes Malta's figure about 1.1 times Syria's.
Across all 25 years both countries report, Malta has been ahead every year.
Malta ranks 124th and Syria ranks 127th of 141 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.5% | 5.4% | 19.1% | Malta |
| 2010s | 49.1% | 26.9% | 22.2% | Malta |
| 2020s | 68.4% | 41.4% | 27.0% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Malta or Syria?
- Malta, at 47.0% against 41.0% in Syria as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Malta and Syria?
- 6.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Syria?
- 25 years are reported by both, from 2000 to 2024.
- How do Malta and Syria rank globally for access to anti-retroviral drugs, female?
- Malta ranks 124th and Syria ranks 127th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.